FPIN's Help Desk Answers

Hydrochlorothiazide vs. Chlorthalidone for the Treatment of Hypertension

 

Am Fam Physician. 2021 Aug ;104(2):203.

Clinical Question

Is hydrochlorothiazide more effective than chlorthalidone for the treatment of hypertension?

Evidence-Based Answer

Chlorthalidone reduces systolic blood pressure (SBP) by 10 mm Hg more than hydrochlorothiazide at equal dosages (12.5 to 25 mg daily) in patients using monotherapy. (Strength of Recommendation [SOR]: B, meta-analysis of randomized controlled trials [RCTs].) Low-dose chlorthalidone (6.25 mg daily) and controlled-release hydrochlorothiazide (12.5 mg daily; not currently available in the United States) reduce 24-hour ambulatory SBP and diastolic blood pressure (DBP), whereas immediate-release hydrochlorothiazide (12.5 mg daily) may only reduce daytime SBP. (SOR: B, single RCT.)

Evidence Summary

A 2010 meta-analysis (137 RCTs; N = 10,443) evaluated the effect of hydrochlorothiazide and chlorthalidone on SBP and serum potassium.1 Adult patients were on hydrochlorothiazide or chlorthalidone monotherapy. Further patient demographics were not defined. Chlorthalidone dosing ranged from 12.5 to 200 mg daily (mean dosage = 31.6 mg daily) with an average baseline SBP of 166 mm Hg (29 RCTs; n = 4,380). Hydrochlorothiazide dosing ranged from 3 to 450 mg daily (mean dosage = 42.7 mg daily) with an average baseline SBP of 163 mm Hg (108 RCTs; n = 6,063). Studies lasted four to 52 weeks. Pooled results showed that chlorthalidone (12.5 to 25 mg daily) reduced SBP more than hydrochlorothiazide at the same dosage (137 RCTs; N = 10,443; −24 mm Hg vs. −14 mm Hg, respectively; P < .05). However, chlorthalidone also caused larger decreases in serum potassium levels (−0.4 mEq per L [–0.4 mmol per L] vs. −0.2 mEq per L [–0.2 mmol per L], respectively; P < .05). Heterogeneity was not reported. The analysis was limited to patients with hypertension who were on monotherapy.

A 2016 RCT (N = 54) evaluated the effect of low-dose chlorthalidone and hydrochlorothiazide on mean 24-hour ambulatory blood pressure.2 Patients were 18 to 65 years of age (mean = 45 years

Address correspondence to Jason M. Barnes, MD, at jason.m.barnes.mil@mail.mil. Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations.

References

1. Ernst ME, Carter BL, Zheng S, et al. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010;23(4):440–446.

2. Pareek AK, Messerli FH, Chandurkar NB, et al. Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. J Am Coll Cardiol. 2016;67(4):379–389.

Help Desk Answers provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email: questions@fpin.org.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN's Help Desk Answers published in AFP is available at https://www.aafp.org/afp/hda.

 

 

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP


Editor's Collections


Related Content


MOST RECENT ISSUE


Oct 2021

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article